Advanced search
Publication Cover
Journal of Medical Economics Volume 26, 2023 - Issue 1
Submit an article Journal homepage
872
Views
0
CrossRef citations to date
0
Altmetric
Genetic Disease

Re: Response letter to Sanofi’s communication related to “the budget impact of enzyme replacement therapy in type 1 Gaucher disease in the United States”

Sepehr Farahbakhshiana US Medical, Takeda Pharmaceuticals U.S.A., Inc., Lexington, MA, USACorrespondence[email protected]
,
Timothy J. Inocenciob Modeling and Meta-analysis, OPEN Health, Bethesda, MD, USA
,
Gregory Poormanb Modeling and Meta-analysis, OPEN Health, Bethesda, MD, USA
,
Ekaterina Wrighta US Medical, Takeda Pharmaceuticals U.S.A., Inc., Lexington, MA, USA
,
Ravi Ramesh Pathaka US Medical, Takeda Pharmaceuticals U.S.A., Inc., Lexington, MA, USA
&
Michael Bullanoa US Medical, Takeda Pharmaceuticals U.S.A., Inc., Lexington, MA, USAORCID Iconhttps://orcid.org/0000-0002-9961-4576
ORCID Icon
Pages 581-583 | Received 28 Mar 2023, Accepted 29 Mar 2023, Published online: 17 Apr 2023

Figures & data

This paper does not have figures.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.